Project Grant HT94252510932
- This $1,211,469 Project Grant, awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a therapeutic intervention research project to reverse gastric precancer conducted by Vanderbilt University Medical Center (VUMC). The award, with a performance period from June 1, 2024 to May 31, 2028, will enable VUMC to leverage its clinical expertise and research capabilities to advance medical knowledge and improve patient care. As a leading...
- The U.S. Department of Defense's Defense Health Agency awarded a $1,317,028 Project Grant to Vanderbilt University Medical Center (VUMC) with a period of performance from June 1, 2024 to May 31, 2028. The grant, under CFDA 12.420 - Military Medical Research and Development program, will support VUMC's research into therapeutic interventions to reverse gastric precancer. As a leading academic medical center and biomedical research institution, VUMC will leverage its clinical expertise and...
- This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) provides $3,640,918.00 to Vanderbilt University Medical Center (VUMC) to fund research aimed at improving outcomes for spine surgery patients through the development of innovative rehabilitation strategies. The 4-year award, which commenced on September 1, 2025, is focused on transforming healthcare for military service members, veterans, and the broader...
- This federal Project Grant award of $1,267,303.00 from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) supports research to define chronic immune-related adverse events in melanoma survivors. The funding period extends from August 1, 2025 to July 31, 2028. As a prominent academic medical center and federal contractor, VUMC has demonstrated extensive capabilities in providing specialized medical research...
- This federal Project Grant award of $2,264,623.00 was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The purpose of the grant is to conduct research on toxicant-mediated pulmonary hypertension in Southwest Asia veterans. The award has a performance period from May 1, 2025 to April 30, 2029. As a leading academic medical center, VUMC has demonstrated extensive...
- This Project Grant award, totaling $2,399,874.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to Vanderbilt University Medical Center (VUMC) for a project titled "Decoding the Inflammatory Spark and Fire: Unraveling the Molecular Basis of Post-Injury Syndrome and Mineralization Disorders". The award supports advanced biomedical research aimed at transforming healthcare for military service members, veterans, and...
- The Department of the Army Medical Command awarded Vanderbilt University Medical Center (VUMC) a $1,310,914 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on monitoring peripheral immunity to chemotherapy and immunotherapy in breast cancer. The 3-year award, which began on February 1, 2024, aims to advance the understanding of biomarkers and identify novel therapies for breast cancer treatment. As a leading academic medical center with...
- This $700,000 Project Grant, awarded on August 15, 2025 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports research conducted by Vanderbilt University Medical Center (VUMC) to target the DPEP1-neutrophil axis in microsatellite stable colorectal cancer. The funding will enable VUMC, a prominent academic medical center, to advance biomedical research focused on developing innovative medical solutions to address critical health...
- This $750,000 federal Project Grant award from the Department of Defense's Defense Health Agency supports research by Vanderbilt University Medical Center (VUMC) on small RNAs and the heterogeneity of risk for developing systemic lupus erythematosus. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which focuses on biomedical research related to military medicine. VUMC, a leading academic medical center and nonprofit healthcare provider, will...
- The Department of the Army Medical Command awarded a $782,955.27 Project Grant to Vanderbilt University Medical Center on September 15, 2022, with a completion date of September 14, 2025. The grant supports research under the Military Medical Research and Development program (CFDA 12.420) to modulate lung and bone microenvironments to treat breast cancer metastases. The program aims to transform military and public health through innovative biomedical research solutions for battlefield...
This $1,847,457.00 Project Grant award, funded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports advanced biomedical research conducted by Vanderbilt University Medical Center (VUMC) in Nashville, Tennessee. The research aims to transform healthcare for military service members, veterans, and the broader public through innovative and impactful studies across various medical domains, including cancer, neuroscience, infectious diseases, and injury prevention. VUMC, a prominent academic medical center and federal grant recipient, will leverage its expertise in specialized medical research, clinical services, and scientific support to execute this 5-year project, which commenced on September 1, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.8m | 9/3/25 |